Internal Medicine, ISSN 0918-2918, 2017, Volume 56, Issue 23, pp. 3153 - 3158
Objective To evaluate the effectiveness of an early detection program for chronic obstructive pulmonary disease (COPD) in a primary care setting in Japan....
primary care | screening | chronic obstructive pulmonary disease | Screening | Primary care | Chronic obstructive pulmonary disease | DIAGNOSIS | POPULATION | VALIDATION | AIRWAY-OBSTRUCTION | MEDICINE, GENERAL & INTERNAL | FVC | QUESTIONNAIRE | BURDEN | COPD | FEV6 | Body Mass Index | Japan - epidemiology | Pulmonary Disease, Chronic Obstructive - diagnosis | Humans | Middle Aged | Primary Health Care - organization & administration | Male | Lung - physiopathology | Pulmonary Disease, Chronic Obstructive - physiopathology | Mass Screening - methods | Pulmonary Disease, Chronic Obstructive - epidemiology | Forced Expiratory Volume | Smoking - epidemiology | Spirometry - methods | Adult | Female | ROC Curve | Aged | Early Diagnosis | Radiography | Health care | Air flow | Body mass | Lung diseases | Obstructive lung disease | Diagnosis | Patients | Smoking | Chronic illnesses | Original
primary care | screening | chronic obstructive pulmonary disease | Screening | Primary care | Chronic obstructive pulmonary disease | DIAGNOSIS | POPULATION | VALIDATION | AIRWAY-OBSTRUCTION | MEDICINE, GENERAL & INTERNAL | FVC | QUESTIONNAIRE | BURDEN | COPD | FEV6 | Body Mass Index | Japan - epidemiology | Pulmonary Disease, Chronic Obstructive - diagnosis | Humans | Middle Aged | Primary Health Care - organization & administration | Male | Lung - physiopathology | Pulmonary Disease, Chronic Obstructive - physiopathology | Mass Screening - methods | Pulmonary Disease, Chronic Obstructive - epidemiology | Forced Expiratory Volume | Smoking - epidemiology | Spirometry - methods | Adult | Female | ROC Curve | Aged | Early Diagnosis | Radiography | Health care | Air flow | Body mass | Lung diseases | Obstructive lung disease | Diagnosis | Patients | Smoking | Chronic illnesses | Original
Journal Article
Chest, ISSN 0012-3692, 09/2005, Volume 128, Issue 3, pp. 1475 - 1482
To evaluate the effect of anticoagulant therapy on the survival of patients with idiopathic pulmonary fibrosis (IPF). Prospective study. Five hospitals located...
survival | acute exacerbation | low-molecular-weight heparin | idiopathic pulmonary fibrosis | prognosis | anticoagulant therapy | warfarin | Warfarin | Prognosis | Idiopathic pulmonary fibrosis | Low-molecular-weight heparin | Acute exacerbation | Survival | Anticoagulant therapy | DIAGNOSIS | LUNGS | INJURY | idiopathic pulmonary fibrrosis | ACCURACY | FIBRIN DEPOSITION | RESPIRATORY SYSTEM | INFLAMMATION | DISEASE | COAGULATION | D-DIMER | Prospective Studies | Pulmonary Fibrosis - complications | Fibrin Fibrinogen Degradation Products - analysis | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Pulmonary Fibrosis - blood | Treatment Outcome | Hospitalization | Biomarkers - blood | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - therapeutic use | Blood Coagulation Disorders - drug therapy | Survival Analysis | Aged, 80 and over | Anti-Inflammatory Agents - therapeutic use | Blood Coagulation Disorders - blood | Female | Aged | Prednisolone - therapeutic use | Pulmonary Fibrosis - drug therapy | Blood Coagulation Disorders - complications | Case studies | Pulmonary fibrosis | Anticoagulants (Medicine) | Heparin | Drug therapy | Health aspects
survival | acute exacerbation | low-molecular-weight heparin | idiopathic pulmonary fibrosis | prognosis | anticoagulant therapy | warfarin | Warfarin | Prognosis | Idiopathic pulmonary fibrosis | Low-molecular-weight heparin | Acute exacerbation | Survival | Anticoagulant therapy | DIAGNOSIS | LUNGS | INJURY | idiopathic pulmonary fibrrosis | ACCURACY | FIBRIN DEPOSITION | RESPIRATORY SYSTEM | INFLAMMATION | DISEASE | COAGULATION | D-DIMER | Prospective Studies | Pulmonary Fibrosis - complications | Fibrin Fibrinogen Degradation Products - analysis | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Pulmonary Fibrosis - blood | Treatment Outcome | Hospitalization | Biomarkers - blood | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - therapeutic use | Blood Coagulation Disorders - drug therapy | Survival Analysis | Aged, 80 and over | Anti-Inflammatory Agents - therapeutic use | Blood Coagulation Disorders - blood | Female | Aged | Prednisolone - therapeutic use | Pulmonary Fibrosis - drug therapy | Blood Coagulation Disorders - complications | Case studies | Pulmonary fibrosis | Anticoagulants (Medicine) | Heparin | Drug therapy | Health aspects
Journal Article
Thorax, ISSN 0040-6376, 12/2012, Volume 67, Issue 12, pp. 1067 - 1074
Rationale The influence of COPD exacerbation on the endothelium is not completely understood. Circulating endothelial microparticles (EMPs) are membrane...
LUNG | APOPTOSIS | OBSTRUCTIVE PULMONARY-DISEASE | ACTIVATION | MARKER | RESPIRATORY SYSTEM | CELLULAR MICROPARTICLES | EMPHYSEMA | DYSFUNCTION | RECEPTORS | DILATION | Platelet Endothelial Cell Adhesion Molecule-1 - blood | Humans | Risk Factors | Cadherins - blood | E-Selectin - blood | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Biomarkers - blood | Chi-Square Distribution | Case-Control Studies | Cell-Derived Microparticles | CD146 Antigen - blood | Regression Analysis | Antigens, CD - blood | Endothelium, Vascular - metabolism | Pulmonary Disease, Chronic Obstructive - blood | Statistics, Nonparametric | Female | Aged | Respiratory Function Tests | Platelet Membrane Glycoprotein IIb - blood | von Willebrand Factor - metabolism | Lung diseases, Obstructive | Blood circulation | Causes of | Physiological aspects | Disease susceptibility | Research | Apoptosis | Endothelium
LUNG | APOPTOSIS | OBSTRUCTIVE PULMONARY-DISEASE | ACTIVATION | MARKER | RESPIRATORY SYSTEM | CELLULAR MICROPARTICLES | EMPHYSEMA | DYSFUNCTION | RECEPTORS | DILATION | Platelet Endothelial Cell Adhesion Molecule-1 - blood | Humans | Risk Factors | Cadherins - blood | E-Selectin - blood | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Biomarkers - blood | Chi-Square Distribution | Case-Control Studies | Cell-Derived Microparticles | CD146 Antigen - blood | Regression Analysis | Antigens, CD - blood | Endothelium, Vascular - metabolism | Pulmonary Disease, Chronic Obstructive - blood | Statistics, Nonparametric | Female | Aged | Respiratory Function Tests | Platelet Membrane Glycoprotein IIb - blood | von Willebrand Factor - metabolism | Lung diseases, Obstructive | Blood circulation | Causes of | Physiological aspects | Disease susceptibility | Research | Apoptosis | Endothelium
Journal Article
Internal Medicine, ISSN 0918-2918, 2017
Objective To evaluate the effectiveness of an early detection program for chronic obstructive pulmonary disease (COPD) in a primary care setting in Japan....
screening | primary care | chronic obstructive pulmonary disease
screening | primary care | chronic obstructive pulmonary disease
Journal Article
Chest, ISSN 0012-3692, 2015, Volume 148, Issue 4, pp. 306A - 306B
Journal Article
Chest, ISSN 0012-3692, 2015, Volume 148, Issue 4, pp. 748A - 748A
Journal Article
Japanese Journal of Chest Diseases, ISSN 0385-3667, 03/2012, Volume 71, Issue 3, pp. 206 - 215
Journal Article
Respiration and Circulation, ISSN 0452-3458, 03/2015, Volume 63, Issue 3, pp. 251 - 254
Journal Article
Respiratory Investigation, ISSN 2212-5345, 2014, Volume 52, Issue 5, pp. 296 - 301
Abstract Background Chronic obstructive pulmonary disease (COPD) is a common disease and an important health care problem in older adults. The impact of age...
Internal Medicine | Pulmonary/Respiratory | Chronic obstructive pulmonary disease | Elderly | Drug adherence | Geriatric condition | Prospective Studies | Age Factors | Cross-Sectional Studies | Comorbidity | Humans | Japan | Middle Aged | Cost of Illness | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - epidemiology | Disease Progression | Activities of Daily Living | Dyspnea | Exercise Tolerance | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Female | Aged | Cognition Disorders - epidemiology | Neoplasms - epidemiology
Internal Medicine | Pulmonary/Respiratory | Chronic obstructive pulmonary disease | Elderly | Drug adherence | Geriatric condition | Prospective Studies | Age Factors | Cross-Sectional Studies | Comorbidity | Humans | Japan | Middle Aged | Cost of Illness | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - epidemiology | Disease Progression | Activities of Daily Living | Dyspnea | Exercise Tolerance | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Female | Aged | Cognition Disorders - epidemiology | Neoplasms - epidemiology
Journal Article
Respiratory Research, ISSN 1465-9921, 09/2016, Volume 17, Issue 1, p. 110
Background: Idiopathic pulmonary fibrosis (IPF) is a disease with a poor prognosis. Although the median survival is 3 years, the clinical course varies to a...
CANCER-CELLS | PATHOGENESIS | VESICLES | RESPIRATORY SYSTEM | EXOSOMES | CLASSIFICATION | MICROVESICLES | MICRORNAS | EXPRESSION | FIBROBLASTS | DISCOVERY | Predictive Value of Tests | Up-Regulation | Idiopathic Pulmonary Fibrosis - genetics | Prognosis | Prospective Studies | Oligonucleotide Array Sequence Analysis | Humans | Male | Cell-Free Nucleic Acids - genetics | Idiopathic Pulmonary Fibrosis - blood | Case-Control Studies | Extracellular Vesicles - metabolism | Time Factors | Extracellular Vesicles - genetics | Polymerase Chain Reaction | Aged, 80 and over | Female | Disease Models, Animal | Mice, Inbred C57BL | Kaplan-Meier Estimate | Proportional Hazards Models | Gene Expression Profiling - methods | Genetic Markers | Animals | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - mortality | Cell-Free Nucleic Acids - blood | Cell Line, Tumor | Aged | MicroRNAs - blood | MicroRNAs - genetics | Measurement | Care and treatment | MicroRNA | Pulmonary fibrosis | Physiological aspects | Genetic aspects | Research
CANCER-CELLS | PATHOGENESIS | VESICLES | RESPIRATORY SYSTEM | EXOSOMES | CLASSIFICATION | MICROVESICLES | MICRORNAS | EXPRESSION | FIBROBLASTS | DISCOVERY | Predictive Value of Tests | Up-Regulation | Idiopathic Pulmonary Fibrosis - genetics | Prognosis | Prospective Studies | Oligonucleotide Array Sequence Analysis | Humans | Male | Cell-Free Nucleic Acids - genetics | Idiopathic Pulmonary Fibrosis - blood | Case-Control Studies | Extracellular Vesicles - metabolism | Time Factors | Extracellular Vesicles - genetics | Polymerase Chain Reaction | Aged, 80 and over | Female | Disease Models, Animal | Mice, Inbred C57BL | Kaplan-Meier Estimate | Proportional Hazards Models | Gene Expression Profiling - methods | Genetic Markers | Animals | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - mortality | Cell-Free Nucleic Acids - blood | Cell Line, Tumor | Aged | MicroRNAs - blood | MicroRNAs - genetics | Measurement | Care and treatment | MicroRNA | Pulmonary fibrosis | Physiological aspects | Genetic aspects | Research
Journal Article
Thorax, ISSN 0040-6376, 10/2017, Volume 72, Issue 10, pp. 893 - 904
RationaleCellular senescence is observed in the lungs of patients with COPD and may contribute to the disease pathogenesis. Growth differentiation factor 11...
LUNG | CELLS | OXIDATIVE STRESS | RESPIRATORY SYSTEM | COMORBIDITIES | EMPHYSEMA | MICE | MECHANISMS | CELLULAR SENESCENCE | FIBROBLASTS | COPD | Immunohistochemistry | Plasma | Smoke - adverse effects | Humans | Male | RNA, Messenger - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Bone Morphogenetic Proteins - metabolism | Growth Differentiation Factors - metabolism | Animals | Cellular Senescence | Growth Differentiation Factors - pharmacology | Female | Aged | Mice | Pulmonary Disease, Chronic Obstructive - metabolism | Respiratory Function Tests | Bone Morphogenetic Proteins - pharmacology | Disease Models, Animal | Myostatin | Lung diseases, Obstructive | Care and treatment | Usage | Cellular signal transduction | Research | Oxidative stress | Senescence | Disease | Pathogenesis | Lung cancer | Mortality | Experiments | Studies | Ethics | Hospitals | Fibroblasts | Aging | Chronic obstructive pulmonary disease | Growth factors | Emphysema | Age | Smoking | Index Medicus
LUNG | CELLS | OXIDATIVE STRESS | RESPIRATORY SYSTEM | COMORBIDITIES | EMPHYSEMA | MICE | MECHANISMS | CELLULAR SENESCENCE | FIBROBLASTS | COPD | Immunohistochemistry | Plasma | Smoke - adverse effects | Humans | Male | RNA, Messenger - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Bone Morphogenetic Proteins - metabolism | Growth Differentiation Factors - metabolism | Animals | Cellular Senescence | Growth Differentiation Factors - pharmacology | Female | Aged | Mice | Pulmonary Disease, Chronic Obstructive - metabolism | Respiratory Function Tests | Bone Morphogenetic Proteins - pharmacology | Disease Models, Animal | Myostatin | Lung diseases, Obstructive | Care and treatment | Usage | Cellular signal transduction | Research | Oxidative stress | Senescence | Disease | Pathogenesis | Lung cancer | Mortality | Experiments | Studies | Ethics | Hospitals | Fibroblasts | Aging | Chronic obstructive pulmonary disease | Growth factors | Emphysema | Age | Smoking | Index Medicus
Journal Article
Physical Review B - Condensed Matter and Materials Physics, ISSN 1098-0121, 03/2014, Volume 89, Issue 10
Journal Article
The Lancet, ISSN 0140-6736, 03/2019, Volume 393, Issue 10176, pp. 1128 - 1137
Genetic studies have indicated possible involvement of the upregulated calcium-nuclear factor of activated T cells pathway in the pathogenesis of Kawasaki...
MEDICINE, GENERAL & INTERNAL | THERAPY | EPIDEMIOLOGY | SUSCEPTIBILITY | GUIDELINES | Medicine, Experimental | Medical research | Product development | Kawasaki disease | Cyclosporine | Transcription factors | Intravenous administration | Calcium | Pathogenesis | Medical services | Clinical trials | Nuclear engineering | Risk | NF-AT protein | Incidence | Randomization | Illnesses | Lymphocytes | Immunoglobulins | Echocardiography | Research & development--R&D | Abnormalities | Coronary artery | Health risks | Patients | Fever | Disease prevention | Nuclear safety | Coronary vessels | Mucocutaneous lymph node syndrome | Health risk assessment | Veins & arteries
MEDICINE, GENERAL & INTERNAL | THERAPY | EPIDEMIOLOGY | SUSCEPTIBILITY | GUIDELINES | Medicine, Experimental | Medical research | Product development | Kawasaki disease | Cyclosporine | Transcription factors | Intravenous administration | Calcium | Pathogenesis | Medical services | Clinical trials | Nuclear engineering | Risk | NF-AT protein | Incidence | Randomization | Illnesses | Lymphocytes | Immunoglobulins | Echocardiography | Research & development--R&D | Abnormalities | Coronary artery | Health risks | Patients | Fever | Disease prevention | Nuclear safety | Coronary vessels | Mucocutaneous lymph node syndrome | Health risk assessment | Veins & arteries
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 9/2018, Volume 53, Issue 9, pp. 1065 - 1078
Despite NUDT15 variants showing significant association with thiopurine-induced adverse events (AEs) in Asians, it remains unclear which variants of NUDT15 or...
Inflammatory bowel disease | Pharmacogenetics | GWAS | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Thiopurine | Abdominal Surgery | NUDT15 | Surgical Oncology | S-METHYLTRANSFERASE | VARIANTS | GENOTYPE | COMBINATION THERAPY | SUSCEPTIBILITY | AZATHIOPRINE | INTOLERANCE | POLYMORPHISMS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Haplotypes | Azathioprine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Biomarkers, Pharmacological | Pyrophosphatases - genetics | Antibodies, Monoclonal - therapeutic use | Risk | Mercaptopurine - therapeutic use | Leukopenia - chemically induced | Retrospective Studies | Inflammatory Bowel Diseases - drug therapy | Sulfasalazine - therapeutic use | Genetic Predisposition to Disease | Genome-Wide Association Study | Mesalamine - adverse effects | Japan | Mercaptopurine - adverse effects | Logistic Models | Genomic Structural Variation | Mesalamine - therapeutic use | Alopecia - chemically induced | Immunosuppressive Agents - adverse effects | ROC Curve | Sulfasalazine - adverse effects | Azathioprine - adverse effects | Medicine, Experimental | Medical research | Complications and side effects | Codon | Analysis | Gastrointestinal diseases | Genetic variance | Inflammatory bowel diseases | Alopecia | Genotyping | Baldness | Enzymatic activity | Leukopenia | Intestine | Genomes | Original —Alimentary Tract
Inflammatory bowel disease | Pharmacogenetics | GWAS | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Thiopurine | Abdominal Surgery | NUDT15 | Surgical Oncology | S-METHYLTRANSFERASE | VARIANTS | GENOTYPE | COMBINATION THERAPY | SUSCEPTIBILITY | AZATHIOPRINE | INTOLERANCE | POLYMORPHISMS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Haplotypes | Azathioprine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Biomarkers, Pharmacological | Pyrophosphatases - genetics | Antibodies, Monoclonal - therapeutic use | Risk | Mercaptopurine - therapeutic use | Leukopenia - chemically induced | Retrospective Studies | Inflammatory Bowel Diseases - drug therapy | Sulfasalazine - therapeutic use | Genetic Predisposition to Disease | Genome-Wide Association Study | Mesalamine - adverse effects | Japan | Mercaptopurine - adverse effects | Logistic Models | Genomic Structural Variation | Mesalamine - therapeutic use | Alopecia - chemically induced | Immunosuppressive Agents - adverse effects | ROC Curve | Sulfasalazine - adverse effects | Azathioprine - adverse effects | Medicine, Experimental | Medical research | Complications and side effects | Codon | Analysis | Gastrointestinal diseases | Genetic variance | Inflammatory bowel diseases | Alopecia | Genotyping | Baldness | Enzymatic activity | Leukopenia | Intestine | Genomes | Original —Alimentary Tract
Journal Article
Chemistry – An Asian Journal, ISSN 1861-4728, 06/2015, Volume 10, Issue 6, pp. 1299 - 1303
Hierarchical self‐assembly of an amphiphilic tris‐urea in aqueous media is shown. A mixture of the amphiphilic tris‐urea and an alkaline solution gave a...
supramolecular polymers | energy transfer | self-assembly | ureas | gels | lanthanides | Ureas | Self-assembly | Gels | Lanthanides | Energy transfer | Supramolecular polymers | TRIS-UREA | DESIGN | NANOFIBERS | COMPLEXES | GELATION | SELF-ORGANIZATION | CHEMISTRY, MULTIDISCIPLINARY | GEL | LUMINESCENCE | LIGAND | Urea | Optical properties | Analysis
supramolecular polymers | energy transfer | self-assembly | ureas | gels | lanthanides | Ureas | Self-assembly | Gels | Lanthanides | Energy transfer | Supramolecular polymers | TRIS-UREA | DESIGN | NANOFIBERS | COMPLEXES | GELATION | SELF-ORGANIZATION | CHEMISTRY, MULTIDISCIPLINARY | GEL | LUMINESCENCE | LIGAND | Urea | Optical properties | Analysis
Journal Article
BMC Pediatrics, ISSN 1471-2431, 06/2014, Volume 14, Issue 1, pp. 139 - 139
Background: TAFRO syndrome is a unique clinicopathologic variant of multicentric Castleman's disease that has recently been identified in Japan. It is...
Thrombocytopenia | Soluble TNF-receptors | Organomegaly | Tocilizumab | VEGF | Renal dysfunction | reticulin Fibrosis of the bone marrow | Neopterin | Anasarca | IL-6 | PARANEOPLASTIC PEMPHIGUS | PEDIATRICS | Humans | Respiratory Insufficiency - etiology | Male | Thrombocytopenia - drug therapy | Anemia - drug therapy | Lymphatic Diseases - diagnosis | C-Reactive Protein - analysis | Lymphatic Diseases - drug therapy | Acute Kidney Injury - etiology | Anemia - etiology | Cytokines - blood | Primary Myelofibrosis - diagnosis | Primary Myelofibrosis - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Acute Kidney Injury - drug therapy | Japan | Edema - drug therapy | Syndrome | Edema - diagnosis | Bone Marrow - pathology | Adolescent | Thrombocytopenia - diagnosis | Hypoproteinemia - diagnosis | Reticulin | Respiratory Insufficiency - drug therapy | Viral antibodies | Medicine, Experimental | Antibodies | Medical research | Diagnostic imaging | C-reactive protein | Pediatrics | Medical imaging | Pathogenesis | Medical treatment | Patients | Blood | Proteins | Medicine | Pathology | Cell growth | Hospitals | Biopsy | Consent | Herpes viruses | Bone marrow | Tomography | Drug dosages | University graduates
Thrombocytopenia | Soluble TNF-receptors | Organomegaly | Tocilizumab | VEGF | Renal dysfunction | reticulin Fibrosis of the bone marrow | Neopterin | Anasarca | IL-6 | PARANEOPLASTIC PEMPHIGUS | PEDIATRICS | Humans | Respiratory Insufficiency - etiology | Male | Thrombocytopenia - drug therapy | Anemia - drug therapy | Lymphatic Diseases - diagnosis | C-Reactive Protein - analysis | Lymphatic Diseases - drug therapy | Acute Kidney Injury - etiology | Anemia - etiology | Cytokines - blood | Primary Myelofibrosis - diagnosis | Primary Myelofibrosis - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Acute Kidney Injury - drug therapy | Japan | Edema - drug therapy | Syndrome | Edema - diagnosis | Bone Marrow - pathology | Adolescent | Thrombocytopenia - diagnosis | Hypoproteinemia - diagnosis | Reticulin | Respiratory Insufficiency - drug therapy | Viral antibodies | Medicine, Experimental | Antibodies | Medical research | Diagnostic imaging | C-reactive protein | Pediatrics | Medical imaging | Pathogenesis | Medical treatment | Patients | Blood | Proteins | Medicine | Pathology | Cell growth | Hospitals | Biopsy | Consent | Herpes viruses | Bone marrow | Tomography | Drug dosages | University graduates
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 05/2013, Volume 187, Issue 9, p. 1029
Journal Article
Internal Medicine, ISSN 0918-2918, 2016, Volume 55, Issue 24, pp. 3645 - 3653
We report two cases of organizing pneumonia (OP) secondary to the inhalation of the dried tsunami sludge which formed during the 2011 Great East Japan...
tsunami | organizing pneumonia | electron probe microanalysis (EPMA) | earthquake | Tsunami | Organizing pneumonia | Electron probe microanalysis (EPMA) | Earthquake | SILICA EXPOSURE | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CITY | PULMONARY SILICOSIS
tsunami | organizing pneumonia | electron probe microanalysis (EPMA) | earthquake | Tsunami | Organizing pneumonia | Electron probe microanalysis (EPMA) | Earthquake | SILICA EXPOSURE | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CITY | PULMONARY SILICOSIS
Journal Article